Lixte Biotechnology Inc. (LIXTW)

AI Score

Unlock

0.03

0.00 (0.00%)

At close: Apr 22, 2025, 10:01 AM

Lixte Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-3.59M	-4M	-4.03M	-4.69M	-5.09M	-5.69M	-6.15M	-6.02M	-6.31M	-6.71M	-6.47M	-6.66M	-6.73M	-5.61M	-5.97M	-4.61M	-3.26M	-2.68M	-2.16M	-2.39M	-2.44M	-2.47M	-2.42M	-2.18M	-2.13M	-2.22M	-1.65M	-1.57M	-1.81M	-1.89M	-2.08M	-2.34M	-2.13M	-2.23M	-2.37M	-2.31M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	311.6K	337.68K	449.78K	599.15K	773.2K	1.05M	1.34M	1.48M	1.55M	1.91M	1.86M	2.28M	2.6M	2.04M	2.76M	1.91M	1.25M	316.09K	-309.6K	-12.94K	n/a	761.88K	1.1M	798.55K	785.61K	805.38K	48.95K	-1.24K	70.69K	30.73K	160.57K	389.47K	287.16K	417.43K	529.38K	435.33K
Other Working Capital	-33.6K	116.81K	364.79K	258.33K	94.54K	118.18K	-163.68K	-349.97K	-36.79K	-24.56K	113.3K	70.08K	17.66K	-203.16K	-253.56K	-75.6K	-210.03K	-120.35K	18.9K	-15.43K	53.74K	17.65K	-58.6K	-30.76K	-46.7K	-40.36K	7.38K	11.06K	173.1K	182.24K	144.69K	109.63K	-74.76K	-209.95K	-226.52K	-280.48K
Other Non-Cash Items	181.79K	181.79K	270.46K	407.62K	677.74K	1.14M	1.35M	1.21M	1.12M	1.39M	1.22M	2.06M	2.56M	1.83M	1.53M	697.43K	-31.84	748.59K	748.69K	748.71K	748.75K	-149.72	772.15K	772.28K	772.11K	805.35K	48.92K	-1.38K	70.69K	30.73K	160.57K	389.47K	287.16K	417.43K	529.38K	435.33K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-58.96K	26.07K	128.7K	280.42K	20.56K	31.95K	-23.12K	-308.08K	154.76K	254.94K	311.37K	223.93K	-13.44K	-169.81K	-220.21K	-42.25K	-117.88K	-154.63K	-15.38K	-49.71K	17.54K	-168.27K	-123.8K	-8.58K	-163.52K	193.05K	82.16K	-12.67K	325.54K	263.63K	298.59K	268.76K	170.13K	-4.97K	-12.98K	-92.98K
Operating Cash Flow	-3.16M	-3.47M	-3.45M	-3.81M	-4.29M	-4.6M	-4.83M	-4.85M	-4.61M	-4.55M	-4.3M	-4.15M	-4.14M	-3.74M	-3.43M	-2.74M	-2.13M	-1.77M	-1.73M	-1.71M	-1.67M	-1.87M	-1.45M	-1.39M	-1.51M	-1.22M	-1.51M	-1.58M	-1.41M	-1.6M	-1.62M	-1.68M	-1.68M	-1.82M	-1.85M	-1.97M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	-5.14M	n/a	n/a	n/a	5.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	3.14M	3.14M	3.14M	3.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.05M	870.77K	104.09K	524.09K	69.94K	445.99K
Investing Cash Flow	n/a	3.14M	3.14M	3.14M	3.14M	-5.14M	n/a	n/a	n/a	5.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.05M	870.77K	104.09K	524.09K	69.94K	445.99K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2K	-2K	-2K	-2K	-2K	-2K	-2K
Other Financial Acitivies	n/a	3.14M	3.14M	3.14M	3.15M	5.15M	10.29M	10.3M	10.28M	5.15M	100K	190.09K	207.63K	4.93M	4.77M	4.61M	4.6M	-130.24K	-55.85K	n/a	n/a	-24.7K	-21.7K	-21.7K	-21.7K	3K	18K	18K	18K	-1.73M	-1.75M	-1.75M	-1.75M	-1.74M	-1.74M	-1.42M
Financial Cash Flow	n/a	n/a	3.14M	3.14M	3.14M	8.28M	10.29M	15.44M	15.42M	10.29M	5.24M	190.09K	3.9M	8.62M	8.46M	8.3M	4.6M	-130.24K	-55.85K	n/a	n/a	4.48M	4.48M	4.48M	4.48M	3.00	18K	1.52M	2.52M	2.52M	2.5M	1.58M	1.75M	1.72M	1.72M	1.46M
Net Cash Flow	-3.16M	-3.47M	-317.7K	-674.04K	-1.15M	-1.46M	-4.82M	310.56K	529.65K	601.25K	937.29K	-3.96M	-245.52K	4.88M	5.02M	5.55M	2.47M	-1.9M	-1.79M	-1.71M	-1.67M	2.6M	3.03M	3.09M	2.97M	-1.22M	-1.5M	-62.9K	1.11M	920.31K	1.94M	771.55K	174.65K	452.21K	-30.74K	-40.72K
Free Cash Flow	-3.16M	-3.47M	-3.45M	-3.81M	-4.29M	-4.6M	-4.83M	-4.85M	-4.61M	-4.55M	-4.3M	-4.15M	-4.14M	-3.74M	-3.43M	-2.74M	-2.13M	-1.77M	-1.73M	-1.71M	-1.67M	-1.87M	-1.45M	-1.39M	-1.51M	-1.22M	-1.51M	-1.58M	-1.41M	-1.6M	-1.62M	-1.68M	-1.68M	-1.82M	-1.85M	-1.97M